Results 81 to 90 of about 5,625 (178)

Effect of inhaled anticholinergics on bronchial secretions: a systematic review. [PDF]

Front Physiol
Arzayus-Patiño L, Bernal-Sanchez JJ, Pérez-Hortua V, Wilches-Luna EC, Benavides-Cordoba V.   +4 more
europepmc   +1 more source

Acute and 14-day effects of tiotropium/olodaterol on cardiopulmonary function in COPD. [PDF]

ERJ Open Res
Kayser T, Struß N, Pflock R, Heusser K, Kern AL, Voskrebenzev A, Behrendt L, Kaireit TF, Badorrek P, Tank J, Andreas S, Jordan J, Vogel-Claussen J, Hohlfeld JM.   +13 more
europepmc   +1 more source

Real world pharmacovigilance study of FDA adverse event reporting system events for Spiriva Respimat. [PDF]

Front Med (Lausanne)
Chen K, Zhao S, Deng W, Ma Q, Xiao H.
europepmc   +1 more source

Tiotropium in Patients With Airflow Limitation According to the Fixed Ratio But Not the Lower Limit of Normal: A Secondary Analysis of the Tiotropium in Early-COPD Study. [PDF]

Chronic Obstr Pulm Dis
Zhou K, Wu F, Deng Z, Wan Q, Huang S, Zhong N, Zhou Y, Ran P.   +7 more
europepmc   +1 more source

Cardiovascular events in patients with COPD after long-acting bronchodilator initiation. [PDF]

ERJ Open Res
Singh D, Sousa AR, Newby DE, Jonsson Funk M, Roman-Rodriguez M, Kardos P, Requena G, Donald A, Slade D, Compton C.   +9 more
europepmc   +1 more source

Determination of Particle Size of Active Pharmaceutical Ingredients in Dry Powder Inhaler Formulations. [PDF]

Pharmaceuticals (Basel)
Fertaki S, Orkoula M, Kontoyannis C.
europepmc   +1 more source

Whole lung directed anti-muscarinic therapy improves small airway dysfunction in COPD patients. [PDF]

Eur Respir J
Usmani OS, Toumpanakis D, Meah S, Mak V, Biddiscombe MF.   +4 more
europepmc   +1 more source

Lower baseline FEV1 is associated with greater FEV1 improvement after tiotropium add-on in uncontrolled asthma. [PDF]

Medicine (Baltimore)
Shim JS, Ahn KM, Kim MH, Cho YJ.
europepmc   +1 more source

Impact of umeclidinium/vilanterol dual bronchodilator therapy on pulmonary function and inflammatory responses in stable COPD patients. [PDF]

Sci Rep
Jiang R, Zhan W, Jian X, Li J.
europepmc   +1 more source

Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system database. [PDF]

Front Cardiovasc Med
Lan Y, Hu D, Huang S, Xu M, He Q.
europepmc   +1 more source